OpenAI acquires health-tech startup Torch for over USD 100 million
bolt Executive Summary
- OpenAI has acquired US-based health-tech startup Torch. The deal is valued at more than USD 100 million and strengthens OpenAI’s push into healthcare.
- View source

OpenAI has acquired US-based health-tech startup Torch. The deal is valued at more than USD 100 million and strengthens OpenAI’s push into healthcare.
Funding details: More than USD 100 million (Acquisition)
Full Story
OpenAI has acquired US health-tech startup Torch for more than USD 100 million. The acquisition brings Torch into OpenAI’s growing healthcare efforts, including its recently launched ChatGPT Health feature.
Torch has been building a product that helps users bring scattered medical records into one place and use AI to better understand them. OpenAI said Torch’s work fits closely with ChatGPT Health, which lets users upload health data and talk to the chatbot about test results, appointments, diet, and workouts.
OpenAI said privacy will remain a priority. The company has committed that health data and conversations inside ChatGPT Health will stay private and will not be used to train its core AI models. Torch’s leadership team and employees are expected to join OpenAI as part of the deal.
Torch was founded in January 2025 and focuses on helping people make sense of their medical information using AI. The company serves individuals who want a clearer view of their health data and how it connects across hospitals, labs, and devices. It operates in the United States.
Filed Under
Recommended next
View all
Paws Raises INR 29.3 Crore Pre-Series A Led by Chiratae Ventures
Bengaluru-based Dr. Paws raised INR 29.3 crore in pre-Series A funding. Chiratae Ventures led the round with Sauce joining. Trifecta Capital and Stride Ventures provided venture debt.

Earthful Raises INR 26 Crore Pre-Series A Funding
Hyderabad-based Earthful raised INR 26 crore in pre-Series A funding. Fireside Ventures and V3 Ventures led the round. Atrium Angels joined in.

PsiThera raises $47.5 million Series A, names new CEO
PsiThera closed a $47.5 million Series A round. Samsara Biocapital and Lightstone Ventures led. Eric Shaff joins as new CEO.

EpilepsyGTx raises $33 million Series A for epilepsy gene therapy
EpilepsyGTx raised $33 million in Series A funding. XGEN Venture, British Business Bank invested. Funds advance EPY201 through Phase I/IIa trials.
Stay ahead of the curve
Get the latest business and tech insights delivered to your inbox daily.